BR0212598A - Emprego de extratos de tipos de cimicifuga como medicamento organosseletivo para tratamento de doenças do trato urogenital dependentes de hormÈnio sexual - Google Patents

Emprego de extratos de tipos de cimicifuga como medicamento organosseletivo para tratamento de doenças do trato urogenital dependentes de hormÈnio sexual

Info

Publication number
BR0212598A
BR0212598A BR0212598-6A BR0212598A BR0212598A BR 0212598 A BR0212598 A BR 0212598A BR 0212598 A BR0212598 A BR 0212598A BR 0212598 A BR0212598 A BR 0212598A
Authority
BR
Brazil
Prior art keywords
treatment
cimicifuga
drug
organoselective
dependent
Prior art date
Application number
BR0212598-6A
Other languages
English (en)
Inventor
Wolfgang Wuttke
Hubertus Jarry
Volker Christoffel
Barbara Spengler
Original Assignee
Bionorica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionorica Ag filed Critical Bionorica Ag
Publication of BR0212598A publication Critical patent/BR0212598A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

"EMPREGO DE EXTRATOS DE TIPOS DE CIMICIFUGA COMO MEDICAMENTO ORGANOSSELETIVO PARA TRATAMENTO DE DOENçAS DO TRATO UROGENITAL DEPENDENTES DE HORMÈNIO SEXUAL". A presente invenção refere-se a um gênero de extratos de cimicifuga e em particular de cimicifuga racemosa, que são apropriados para produção de um agente pré-formulado para seletivamente tratar e/ou evitar doenças do sistema genito-urinário causadas por hormónios sexuais. Além disso, os extratos da invenção são apropriados para tratamento e/ou prevenção de infecções pós-menopausa da bexiga e para tratamento benigno e maligno da hipertrofia da próstata.
BR0212598-6A 2001-09-19 2002-09-16 Emprego de extratos de tipos de cimicifuga como medicamento organosseletivo para tratamento de doenças do trato urogenital dependentes de hormÈnio sexual BR0212598A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146159A DE10146159A1 (de) 2001-09-19 2001-09-19 Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
PCT/EP2002/010383 WO2003024465A2 (de) 2001-09-19 2002-09-16 Verwendung von extrakten aus cimicifuga-arten als organselektives arzneimittel

Publications (1)

Publication Number Publication Date
BR0212598A true BR0212598A (pt) 2004-10-13

Family

ID=7699541

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212598-6A BR0212598A (pt) 2001-09-19 2002-09-16 Emprego de extratos de tipos de cimicifuga como medicamento organosseletivo para tratamento de doenças do trato urogenital dependentes de hormÈnio sexual

Country Status (16)

Country Link
US (3) US7413754B2 (pt)
EP (1) EP1427430B1 (pt)
JP (1) JP2005503404A (pt)
KR (1) KR20040041619A (pt)
AT (1) ATE293985T1 (pt)
AU (1) AU2002362365A1 (pt)
BR (1) BR0212598A (pt)
DE (2) DE10146159A1 (pt)
DK (1) DK1427430T3 (pt)
EA (1) EA006164B1 (pt)
ES (1) ES2238631T3 (pt)
MX (1) MXPA04002592A (pt)
PL (1) PL206937B1 (pt)
PT (1) PT1427430E (pt)
UA (1) UA78228C2 (pt)
WO (1) WO2003024465A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745796A1 (de) 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
DE102007044916A1 (de) 2007-09-19 2009-04-23 Bionorica Ag Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
MD4025C2 (ro) * 2009-08-25 2010-10-31 Владимир КАРАУШ Remediu pentru tratamentul prostatitei şi hiperplaziei prostatei
KR101303693B1 (ko) 2011-06-30 2013-09-04 한국식품연구원 지방 대사 질환, 폐경기 질환 또는 심혈관질환 개선용 조성물
JP2013010796A (ja) * 2012-10-15 2013-01-17 Kao Corp Ｓ１００ａ８発現調節剤
IT201900000343A1 (it) * 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (ja) 1986-07-23 1988-02-09 Tsumura Juntendo Inc 抗アレルギ−剤
HU204197B (en) 1986-10-30 1991-12-30 Dr Papay Valeria Tothne Process for producing extract for treating aphta, herpes, wounds in the mouth, acne, comedo and pustule
DK0384798T3 (da) 1989-02-06 1993-12-06 Soma Genichiro Limulustest-positivt planteglycolipid samt fremgangsmåde til stimulering af et dyrs immunsystem
US5716646A (en) 1990-05-01 1998-02-10 Smith; Steven A. Methods and compositions for treating arthritis
US5411733A (en) 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
CN1090498A (zh) 1993-02-01 1994-08-10 杨芳林 女用口服避孕中成药及制备方法
JP3294694B2 (ja) 1993-11-15 2002-06-24 一丸ファルコス株式会社 ヒオウギ抽出物を含有する細胞賦活剤とその応用
JP3501832B2 (ja) 1993-11-15 2004-03-02 一丸ファルコス株式会社 ヒオウギ抽出物を含有するテストステロン５α−リダクターゼ阻害剤とその応用
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH0930977A (ja) 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
PL186769B1 (pl) 1995-09-07 2004-02-27 Oreal Zastosowanie wyciągu z Iridaceae i kompozycja zawierająca taki wyciąg
DE69600242T2 (de) 1995-09-07 1998-08-06 Oreal Verwendung von Extrakten aus filamentösen, nicht photosynthetischen Bakterien sowie ihre Zusammensetzungen
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
SE9503775L (sv) 1995-10-26 1997-04-27 Caravan Mill Ab Tekniskt förfarande för torkning, krossning och malning av mussel- och snäckskal
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
CN1159340A (zh) 1996-03-11 1997-09-17 李城林 一种抗癌抑瘤药物的配方及其制作工艺
JPH107580A (ja) 1996-06-15 1998-01-13 Michio Yoshida コラゲナ−ゼ阻害剤
JP3665848B2 (ja) 1996-09-18 2005-06-29 木村 幸代 ヒメヒオウギズイセン球根抽出液の発酵飲料及びその製造方法
CN1057690C (zh) 1996-10-18 2000-10-25 宁振峰 治疗卵巢癌的中成药
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US6039290A (en) 1998-03-16 2000-03-21 Honeywell Inc. Robust singularity avoidance in satellite attitude control
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
US6242012B1 (en) 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
US20010025059A1 (en) * 2000-01-10 2001-09-27 Kastke Floyd A. Composition and method for treating non-bacterial prostatitis
AU2001253070A1 (en) 2000-03-31 2001-10-15 Jonathan Ingram Isoflavones for treatment of obesity
JP2002043945A (ja) 2000-07-19 2002-02-08 Sony Corp ディジタル信号符号化装置及び方法、ディジタル信号復号装置及び方法、並びにディジタル信号伝送システム
US6326366B1 (en) 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
US20020172732A1 (en) 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa

Also Published As

Publication number Publication date
DE10146159A1 (de) 2003-04-10
KR20040041619A (ko) 2004-05-17
DK1427430T3 (da) 2005-05-30
WO2003024465A3 (de) 2003-10-09
EA200400461A1 (ru) 2004-08-26
EP1427430A2 (de) 2004-06-16
PL206937B1 (pl) 2010-10-29
JP2005503404A (ja) 2005-02-03
WO2003024465A2 (de) 2003-03-27
ES2238631T3 (es) 2005-09-01
EP1427430B1 (de) 2005-04-27
US20120071501A1 (en) 2012-03-22
DE50202941D1 (de) 2005-06-02
AU2002362365A1 (en) 2003-04-01
PL370370A1 (en) 2005-05-16
US7413754B2 (en) 2008-08-19
ATE293985T1 (de) 2005-05-15
PT1427430E (pt) 2005-08-31
EA006164B1 (ru) 2005-10-27
US20050019437A1 (en) 2005-01-27
MXPA04002592A (es) 2005-08-26
US20080300230A1 (en) 2008-12-04
UA78228C2 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
WO2008028076A3 (en) Therapeutic devices for the treatment of various conditions of a female individual
EA200701448A1 (ru) Специфически связывающаяся с крипто-антигеном человека молекула (варианты), композиция на ее основе (варианты), способ получения молекулы, способ лечения посредством молекулы (варианты) и способ ингибирования крипто-экспрессии в клетке больного
DK1893196T3 (da) Diarylhydantoin-forbindelse
IL169897A0 (en) Sustituted heterocycles
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
MA31767B1 (fr) Composes organiques et leurs utilisations
WO2008058021A3 (en) Methods of treating neoplastic, autoimmune and inflammatory diseases
DE50109164D1 (de) Therapeutische verwendung von extrakten aus sophora flavescens oder sophora subprostrata
MY149606A (en) Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
TW200801031A (en) Steroid nitrooxyderivatives
WO2006109301A3 (en) Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
WO2007100920A3 (en) Diagnosis and treatment of prostate cancer
ATE412412T1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1 -pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata-oder gebahrmutterkrebs
HK1116186A1 (en) Azaxanthones and use thereof for treating tumors
MA30485B1 (fr) Aminothiazoles et leurs utilisations
BR0212598A (pt) Emprego de extratos de tipos de cimicifuga como medicamento organosseletivo para tratamento de doenças do trato urogenital dependentes de hormÈnio sexual
WO2007048097A3 (en) Anbrosteeone derivatives and method of use thereof
WO2007086943A3 (en) Wortmannin conjugates and uses thereof
PT1411971E (pt) Utilizacao de pentraxina longa ptx3 para o tratamento de infertilidade feminina
WO2006065968A3 (en) The uses of estrogen beta agonists to treat cognitive diseases
PT1315496E (pt) Tratamento de desordens inflamatorias
NO20072048L (no) Anvendelse av IL-17F for behandling og/eller forebygging av neurologiske sykdommer.
UA3728U (uk) Спосіб лікування синдрому рокитанського-кюстера-майєра
PL1732574T3 (pl) Zastosowanie o-ATP do leczenia chorób związanych z angiogenezą
TW200610547A (en) Nanosilver gels and use thereof

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 35/78 , A61P 13/00 , A61P 15/00

Ipc: A61K 36/71 (2006.01), A61P 13/00 (2006.01), A61P 1

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2271 DE 15/07/2014